Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Department of Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois (email@example.com).
To the Editor: The meta-analysis by Dr Rizos and colleagues1 synthesized the available evidence on omega-3 PUFA supplementation to prevent adverse cardiovascular outcomes. In addition to conventional random-effects meta-analyses, subgroup analyses and meta-regressions were performed. No association with type of prevention (ie, mixed or secondary) or omega-3 dose was found, and the authors did not demonstrate a net benefit from omega-3 PUFA supplementation after 2007. However, the type of omega-3 PUFA supplements and co-administered medications were not adequately explored.
Sethi A, Singh M, Arora R. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events. JAMA. 2013;309(1):27. doi:10.1001/jama.2012.116644
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: